apollo
0
Written By Santoshini Reddy G , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Nov 10, 2024 | 7:20 PM IST
Ethamcip-250 Tablet is indicated in the treatment of small vessel haemorrhage menorrhagia (menstrual bleeding that lasts more than 7 days), including IUD users and prophylaxis of periventricular haemorrhage in neonates. It prevents and controls bleeding from small blood vessels and neonatal intraventricular haemorrhage. Besides this, it can prevent periventricular haemorrhages in prematurely born children. It contains Etamsylate, which improves platelet adhesion and also inhibits the action of prostaglandin. These effects help to decrease abnormal bleeding. It may cause side effects such as headache, skin rash, nausea and low blood pressure. Before taking this medicine, you should tell your doctor if you are allergic to any of its components or if you are pregnant/breastfeeding, and about all the medications you are taking and pre-existing medical conditions.
Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Composition

ETAMSYLATE-250MG

Manufacturer/Marketer

Cipla Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-27

for this medicine

About Ethamcip-250 Tablet

Ethamcip-250 Tablet belongs to the class of antihemorrhagic drugs. It is indicated in the treatment of small vessel haemorrhage menorrhagia (menstrual bleeding that lasts more than 7 days) including IUD users and prophylaxis of periventricular haemorrhage in neonates. It prevents and controls bleeding from small blood vessels and neonatal intraventricular haemorrhage. Besides this, Ethamcip-250 Tablet can prevent periventricular haemorrhages in prematurely born children.

Ethamcip-250 Tablet contains Etamsylate, a hemostatic agent that improves platelet adhesion by restoring capillary resistance and improving platelet adhesion. On the other hand, this medicine also inhibits the biosynthesis and action of prostaglandin. These effects help to decrease abnormal bleeding.

Ethamcip-250 Tablet should be used as prescribed by the physician. Ethamcip-250 Tablet may cause side effects such as headache, skin rash, nausea and low blood pressure. These side effects are short and may go away with time; however, if they continue, consult a doctor.

Inform your doctor if you are allergic to any medications and foods, if you have acute porphyria, fever, non-cancerous growths or blood pigment disorder, or if you are pregnant or breastfeeding. Ethamcip-250 Tablet is not recommended to use before the onset of bleeding during periods, so inform your doctor about your condition. And also, notify your doctor about your current list of medications, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.) in order to rule out any potential negative effects.

Uses of Ethamcip-250 Tablet

Treatment of Bleeding disorders (preventing and controlling bleeding from small blood vessels haemorrhage menorrhagia, neonatal intraventricular and periventricular haemorrhages).

Medicinal Benefits

Ethamcip-250 Tablet contains Etamsylate, a hemostatic agent that improves platelet adhesion by restoring capillary resistance and improving platelet adhesion. On the other hand, Ethamcip-250 Tablet also inhibits the biosynthesis and action of the prostaglandin. These effects help to decrease abnormal bleeding. Thus it treats, controls, and improves various disease conditions and symptoms.

Directions for Use

Swallow it as a whole with water; do not crush, break or chew it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Ethamcip-250 Tablet

  • Headache
  • Skin Rash
  • Nausea
  • Low Blood Pressure

Drug Warnings

Before prescribing the Ethamcip-250 Tablet , let your doctor know if you are allergic to any medications and foods if you have acute porphyria, bronchial asthma, fever, non-cancerous growths or blood pigment disorder, or if you are pregnant or breastfeeding a baby. Ethamcip-250 Tablet is recommended not to use before the onset of bleeding during periods, so inform your doctor about your condition. And also, inform your doctor about your current list of medications (including vitamins and supplements), pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.) in order to rule out any potential negative effects.

Drug Interactions

Drug-Drug interactions: No interactions found or established.

Drug-Food interactions: No interactions found or established.

Drug-Disease interactions: Ethamcip-250 Tablet may interact with disease conditions, including bronchial asthma, acute porphyria, fever, non-cancerous growths or blood pigment disorder. So, inform your doctor about your medical condition.

Habit Forming

No

Diet & Lifestyle Advise

  • Maintain a healthy weight. Stay physically active.
  • Consume fresh fruits and vegetables. Avoid spicy, salty, and deep-fried foods. Eating healthy can help you to recover faster.
  • Avoid tea, coffee, and cold drinks.
  • Drink plenty of fluids to stay hydrated. Fluids are necessary to maintain blood flow in your body.
  • Avoid the intake of alcoholic beverages as it can make you dehydrated and also can affect your sleep.
  • Avoid physical and psychological stress.

Disease/Condition Glossary

Bleeding disorders: Bleeding disorders are a group of diseases that occur when the blood fails to clot properly. Platelets, a type of blood cell, stick together and form a plug at the site of an injured blood vessel during normal clotting. Clotting factors, which are proteins in the blood, then interact to form a fibrin clot, which is essentially a gel plug that holds platelets in place and allows healing to occur at the site of the injury while preventing blood from escaping the blood vessel. While excessive clotting can result in conditions such as heart attacks and strokes, the inability to form clots can be equally dangerous, resulting in excessive bleeding. Bleeding can occur as a result of insufficient or abnormal platelets, insufficient or abnormal clotting proteins, or abnormal blood vessels.

Haemorrhage menorrhagia: Menstrual periods with very excessive or protracted bleeding are known medically as menorrhagia. Despite the fact that most women worry about their periods being heavy, menorrhagia is not a regular occurrence in most women.

Neonatal intraventricular haemorrhage: A newborn’s intraventricular haemorrhage (IVH) is bleeding into the fluid-filled regions, or ventricles, that surround the brain. The condition is more common in preterm babies, and the smaller and more premature the infant, the greater the risk for IVH. This is due to the fact that blood vessels in premature infants' brains have not yet fully matured and are extremely fragile. IVH is rarely present at birth, and if it does occur, it is usually in the first few days of life.

Periventricular-intraventricular haemorrhage is a disorder that primarily affects premature newborn infants born before 33 weeks of gestation. Haemorrhage develops when arteries in the periventricular portion of the germinal matrix break and expand into the intraventricular space. Periventricular haemorrhage occurs when bleeding extends into the intraparenchymal area next to the ventricle.

bannner image

Alcohol

Caution

The interaction of alcohol with Ethamcip-250 Tablet is unknown. Please consult a doctor if you have any concerns.

bannner image

Pregnancy

Safe if prescribed

Inform your doctor if you are pregnant or suspect pregnancy. Your doctor will weigh the benefits and potential risks before prescribing Ethamcip-250 Tablet .

bannner image

Breast Feeding

Safe if prescribed

Inform your doctor if you are a nursing mother. Your doctor will weigh the benefits and potential risks before prescribing Ethamcip-250 Tablet .

bannner image

Driving

Safe if prescribed

Ethamcip-250 Tablet has no or negligible influence on the ability to drive and operate machines.

bannner image

Liver

Caution

If you have or history or evidence of liver disease, please inform the doctor before prescribing Ethamcip-250 Tablet . Your doctor may adjust the dose based on your condition.

bannner image

Kidney

Caution

If you have or history or evidence of kidney disease, please inform the doctor before prescribing Ethamcip-250 Tablet . Your doctor may adjust the dose based on your condition.

bannner image

Children

Safe if prescribed

Etamsylate should be used in children and neonates under the supervision of a doctor.

Country of origin

India

Manufacturer/Marketer address

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Other Info - ETH0014

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Ethamcip-250 Tablet is indicated in the treatment of small vessel haemorrhage menorrhagia (menstrual bleeding that lasts more than 7 days) including IUD users and prophylaxis of periventricular haemorrhage in neonates. It prevents and controls bleeding from small blood vessels and neonatal intraventricular haemorrhage. Besides this, Ethamcip-250 Tablet can prevent periventricular haemorrhages in prematurely born children.
Etamsylate, a hemostatic substance found in Ethamcip-250 Tablet , works by restoring capillary resistance and enhancing platelet adhesion. On the other hand, Ethamcip-250 Tablet also inhibits the biosynthesis and action of the prostaglandin. These effects help to decrease abnormal bleeding.
Yes, Ethamcip-250 Tablet is contraindicated in people with known allergies to any of the components of this medicine. It should be avoided in people with porphyria (a group of rare inherited blood disorders).
In case you have missed a dose, skip the missed dose. Then resume your next dose as normal. Do not take a double dose in any case.
No, you are not recommended to stop using Ethamcip-250 Tablet without consulting your doctor, as it may cause recurring bleeding. Therefore, take Ethamcip-250 Tablet for as long as your doctor has prescribed it, and if you are experiencing any difficulty while taking Ethamcip-250 Tablet , please consult your doctor.
Majority of cases, Ethamcip-250 Tablet is prescribed by your doctor for prevention and control of bleeding from small blood vessels haemorrhage menorrhagia and neonatal intraventricular haemorrhage. Besides this, it can also be used to prevent periventricular haemorrhages in prematurely born children.
Ethamcip-250 Tablet may cause side effects such as headache, skin rash, nausea and low blood pressure. These side effects are short and may go away with time; however, if they continue, consult a doctor.
Ethamcip-250 Tablet is used to treat menorrhagia (menstrual bleeding that lasts more than 7 days). It is not recommended for use before the onset of bleeding during periods; therefore, it should not be used to avoid getting menses.
Let the doctor know if you have any other medical conditions or if you are taking any other medicines. Consult the doctor if you are pregnant or breastfeeding.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Add to Cart